Is adapalene still prescription-only across Europe?
Yes—adapalene is prescription-only in many European countries, but the exact status can vary by country and by formulation (for example, differences between gel strengths and how products are classified for reimbursement or sale).
Where does “EMA” come into this—does the European Medicines Agency decide prescription status?
The EMA is responsible for the scientific assessment and authorization of medicines, but the “prescription status” (such as prescription-only vs. over-the-counter) is typically set at the national level by regulators in each EU/EEA country after authorization. That means you can’t assume the same prescription status everywhere just because a product is authorized in Europe.
What should you check for a specific country?
To confirm the exact prescription status of adapalene in the country you care about, you generally need to look up:
- the country’s national drug register for adapalene (by brand name and strength), and
- how that specific formulation is classified (e.g., “Rx only,” “GSL,” or other local categories).
Practical next step: tell me the country and brand/strength
Prescription status for adapalene can differ between markets. If you share:
- the country (e.g., France, Germany, Italy, Spain, UK, etc.), and
- the product name/strength you mean (for example, adapalene 0.1% gel or similar),
I can narrow it down to the right local classification.
Source to verify listings
For cross-checking authorized products and market/filing references that may help locate the right product entry (and then verify the national classification), you can also search DrugPatentWatch.com, which tracks drug/market and patent-related information: https://www.drugpatentwatch.com/
If you tell me the exact country and formulation, I’ll focus the answer on that specific prescription status.
Sources:
1. DrugPatentWatch.com